Article Text

PDF
GW24-e1791 Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy
  1. Wen Liu1,
  2. Dayi Hu1,
  3. Tiangang Zhu1,
  4. Zhanfeng Ma1,
  5. Jie Yang1,
  6. Wenli Xie2,
  7. Cuilan Li1,
  8. Lei Li1,
  9. Jingang Yang3,
  10. Tianchang Li3,
  11. Hong Bian3,
  12. Qiguang Tong3,
  13. Wenling Liu1
  1. 1Heart Center, Peking University People’s Hospital
  2. 2Beijing Electric Power Hospital
  3. 3Tongren Hospital, Capital Medical University

Abstract

Objectives Hypertrophic cardiomyopathy (HC) is a hereditary heterogeneous cardiovascular disorder. Data published to date was mainly in Caucasians and large study is needed in Chinese population. We were aimed to explore the genetic basis and the clinical characteristics correlate with different genotypes in a large cohort of Chinese patients.

Methods Direct sequencing of β-myosin heavy chain (MYH7), myosin binding protein-C (MYBPC3) and cardiac troponin T (TNNT2) genes was performed in 136 unrelated Chinese HC patients. Clinical evaluation was assessed in all patients.

Results In total, 32 mutations were identified in 36 patients (27%), including 10 novel ones. Distribution of mutations was 56% (MYBPC3), 31% (MYH7) and 13% (TNNT2). Double mutations were identified in 3% patients. The occurrence of HC-associated sarcomeric mutations were associated with an earlier age of onset, increased left ventricular hypertrophy, a higher incidence of syncope, family history and sudden cardiac death. No statistical difference was identified in patients carrying MYBPC3 and MYH7 mutations with regard to the clinical characteristics and outcome. Patients with double mutations were associated with malignant clinical process in the study.

Conclusions In conclusion, MYBPC3 is the most predominant gene. Multiple mutations were common in MYH7, MYBPC3 and TNNT2. This study suggested the diversity of HC and a prognostic role of genotype.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.